The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF).

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF). Br J Haematol. 2017 Jan; 176(1):76-85.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Cross-Over Studies
Double-Blind Method
Drug Substitution
Fatigue
Female
Humans
Hydroxyurea
Male
Middle Aged
Nitriles
Polycythemia Vera
Pyrazoles
Pyrimidines
Quality of Life
Treatment Outcome
Young Adult

authors with profiles

Yasmin Hasan